Role of Insulin-like Growth Factor-related Peptides in the Estradiol-, Prolactin-, and Progesterone-stimulated Growth of N-Nitrosomethylurea-induced Rat Mammary Tumors in Soft Agar

Andrea Manni, Carol Wright, Betty Badger, Laurence Deniers, James Lynch

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The present experiments were designed to test the role of insulin-like growth factor-related peptides (IGF-RPs) in hormonally stimulated N-nitrosomethylurea (NMU)-induced mammary tumor colony formation in soft agar. To evaluate production of IGF-RP by NMU cells, we tested the abilities of a monoclonal antibody directed against insulin-like growth factor I (α sm 1.20B) and of a polyclonal antibody raised against the insulin-like growth factor I (Ab 134) to inhibit the colony-stimulating effects of conditioned media (CM) obtained from estradiol (E2) prolactin (PRL)-, and progesterone (Pg)-treated NMU-induced rat mammary tumors. Both Abs abolished the colony-stimulating action of genuine insulin-like growth factor I while having no effect when added alone or with control CM. The addition of either α sm 1.20B or Ab 134 (but not that of an irrelevant Ab) consistently blocked the colony-stimulating action of E2-CM, PRL-CM, and Pg-CM, suggesting that IGF-RPs are produced by NMU mammary tumor cells exposed to these hormones. Next, we directly tested the role of IGF-RPs as mediators of hormonally stimulated growth. We indeed observed that the addition of a sm 1.20B markedly inhibited the colony-stimulating actions of E2, PRL, and Pg added to NMU mammary tumor cells in soft agar in the absence of serum. We conclude that, in our experimental system, IGF-RPs not only are produced upon exposure to E2, PRL, and Pg, but also are important mediators of hormonally stimulated growth.

Original languageEnglish (US)
Pages (from-to)7179-7183
Number of pages5
JournalCancer Research
Volume50
Issue number22
StatePublished - Nov 12 1990

Fingerprint

Methylnitrosourea
Somatomedins
Conditioned Culture Medium
Prolactin
Agar
Progesterone
Estradiol
Breast Neoplasms
Peptides
Insulin-Like Growth Factor I
Growth
Monoclonal Antibodies
Hormones
Antibodies
Serum

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

@article{e3fdccecf647480a8bba936afdd27915,
title = "Role of Insulin-like Growth Factor-related Peptides in the Estradiol-, Prolactin-, and Progesterone-stimulated Growth of N-Nitrosomethylurea-induced Rat Mammary Tumors in Soft Agar",
abstract = "The present experiments were designed to test the role of insulin-like growth factor-related peptides (IGF-RPs) in hormonally stimulated N-nitrosomethylurea (NMU)-induced mammary tumor colony formation in soft agar. To evaluate production of IGF-RP by NMU cells, we tested the abilities of a monoclonal antibody directed against insulin-like growth factor I (α sm 1.20B) and of a polyclonal antibody raised against the insulin-like growth factor I (Ab 134) to inhibit the colony-stimulating effects of conditioned media (CM) obtained from estradiol (E2) prolactin (PRL)-, and progesterone (Pg)-treated NMU-induced rat mammary tumors. Both Abs abolished the colony-stimulating action of genuine insulin-like growth factor I while having no effect when added alone or with control CM. The addition of either α sm 1.20B or Ab 134 (but not that of an irrelevant Ab) consistently blocked the colony-stimulating action of E2-CM, PRL-CM, and Pg-CM, suggesting that IGF-RPs are produced by NMU mammary tumor cells exposed to these hormones. Next, we directly tested the role of IGF-RPs as mediators of hormonally stimulated growth. We indeed observed that the addition of a sm 1.20B markedly inhibited the colony-stimulating actions of E2, PRL, and Pg added to NMU mammary tumor cells in soft agar in the absence of serum. We conclude that, in our experimental system, IGF-RPs not only are produced upon exposure to E2, PRL, and Pg, but also are important mediators of hormonally stimulated growth.",
author = "Andrea Manni and Carol Wright and Betty Badger and Laurence Deniers and James Lynch",
year = "1990",
month = "11",
day = "12",
language = "English (US)",
volume = "50",
pages = "7179--7183",
journal = "Cancer Research",
issn = "0008-5472",
number = "22",

}

Role of Insulin-like Growth Factor-related Peptides in the Estradiol-, Prolactin-, and Progesterone-stimulated Growth of N-Nitrosomethylurea-induced Rat Mammary Tumors in Soft Agar. / Manni, Andrea; Wright, Carol; Badger, Betty; Deniers, Laurence; Lynch, James.

In: Cancer Research, Vol. 50, No. 22, 12.11.1990, p. 7179-7183.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Role of Insulin-like Growth Factor-related Peptides in the Estradiol-, Prolactin-, and Progesterone-stimulated Growth of N-Nitrosomethylurea-induced Rat Mammary Tumors in Soft Agar

AU - Manni, Andrea

AU - Wright, Carol

AU - Badger, Betty

AU - Deniers, Laurence

AU - Lynch, James

PY - 1990/11/12

Y1 - 1990/11/12

N2 - The present experiments were designed to test the role of insulin-like growth factor-related peptides (IGF-RPs) in hormonally stimulated N-nitrosomethylurea (NMU)-induced mammary tumor colony formation in soft agar. To evaluate production of IGF-RP by NMU cells, we tested the abilities of a monoclonal antibody directed against insulin-like growth factor I (α sm 1.20B) and of a polyclonal antibody raised against the insulin-like growth factor I (Ab 134) to inhibit the colony-stimulating effects of conditioned media (CM) obtained from estradiol (E2) prolactin (PRL)-, and progesterone (Pg)-treated NMU-induced rat mammary tumors. Both Abs abolished the colony-stimulating action of genuine insulin-like growth factor I while having no effect when added alone or with control CM. The addition of either α sm 1.20B or Ab 134 (but not that of an irrelevant Ab) consistently blocked the colony-stimulating action of E2-CM, PRL-CM, and Pg-CM, suggesting that IGF-RPs are produced by NMU mammary tumor cells exposed to these hormones. Next, we directly tested the role of IGF-RPs as mediators of hormonally stimulated growth. We indeed observed that the addition of a sm 1.20B markedly inhibited the colony-stimulating actions of E2, PRL, and Pg added to NMU mammary tumor cells in soft agar in the absence of serum. We conclude that, in our experimental system, IGF-RPs not only are produced upon exposure to E2, PRL, and Pg, but also are important mediators of hormonally stimulated growth.

AB - The present experiments were designed to test the role of insulin-like growth factor-related peptides (IGF-RPs) in hormonally stimulated N-nitrosomethylurea (NMU)-induced mammary tumor colony formation in soft agar. To evaluate production of IGF-RP by NMU cells, we tested the abilities of a monoclonal antibody directed against insulin-like growth factor I (α sm 1.20B) and of a polyclonal antibody raised against the insulin-like growth factor I (Ab 134) to inhibit the colony-stimulating effects of conditioned media (CM) obtained from estradiol (E2) prolactin (PRL)-, and progesterone (Pg)-treated NMU-induced rat mammary tumors. Both Abs abolished the colony-stimulating action of genuine insulin-like growth factor I while having no effect when added alone or with control CM. The addition of either α sm 1.20B or Ab 134 (but not that of an irrelevant Ab) consistently blocked the colony-stimulating action of E2-CM, PRL-CM, and Pg-CM, suggesting that IGF-RPs are produced by NMU mammary tumor cells exposed to these hormones. Next, we directly tested the role of IGF-RPs as mediators of hormonally stimulated growth. We indeed observed that the addition of a sm 1.20B markedly inhibited the colony-stimulating actions of E2, PRL, and Pg added to NMU mammary tumor cells in soft agar in the absence of serum. We conclude that, in our experimental system, IGF-RPs not only are produced upon exposure to E2, PRL, and Pg, but also are important mediators of hormonally stimulated growth.

UR - http://www.scopus.com/inward/record.url?scp=0025221246&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025221246&partnerID=8YFLogxK

M3 - Article

C2 - 2224853

AN - SCOPUS:0025221246

VL - 50

SP - 7179

EP - 7183

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 22

ER -